Related Experiment Video
Updated: Aug 12, 2025

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
Published on: July 3, 2020
Multistate models as a framework for estimand specification in clinical trials of complex processes
Alexandra Bühler1, Richard J Cook1, Jerald F Lawless1
1Department of Statistics and Actuarial Science, University of Waterloo, Waterloo, Ontario, Canada.
Intensity-based multistate models aid in analyzing complex clinical trial data, including interventions and patient dropouts. Careful definition of estimands is crucial for interpretable results in randomized trials with intercurrent events.
Area of Science:
- Biostatistics
- Clinical Trials Methodology
- Epidemiology
Background:
- Multistate models are valuable for analyzing complex life history processes in randomized trials.
- Intercurrent events, such as interventions or loss to follow-up, complicate the interpretation of trial outcomes.
- Cumulative incidence function regression models are commonly used for estimating marginal process features.
Purpose of the Study:
- To discuss challenges in specifying estimands within intensity-based multistate models.
- To examine estimators for marginal process features in the presence of intercurrent events.
- To emphasize the importance of interpretable estimands in clinical trial design and analysis.
Main Methods:
- Utilizing intensity-based multistate models.
- Analyzing cumulative incidence function regression models.
- Investigating the specification and interpretation of estimands.
Main Results:
- Identified issues in estimand specification for multistate models.
- Demonstrated limiting values of common estimators for marginal process features.
- Highlighted the need for carefully defined, interpretable target estimands when intercurrent events occur.
Conclusions:
- Intensity-based multistate models offer a robust framework for clinical trial analysis.
- Clear definition of estimands is essential for valid inference, especially with intercurrent events.
- Trial protocols should guide the interpretation of estimands based on marginal features.
Related Concept Videos
Mechanistic Models: Compartment Models in Individual and Population Analysis
Multicompartment Models: Overview
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving
In individual population analyses, different algorithms are employed, such as Cauchy's method, which uses a...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Mechanistic Models: Overview of Compartment Models
Clinical Trials
There are four phases in a clinical trial. A phase one...

